Pharmacists

To ensure and foster continued patient safety and quality of care by clarifying the application of the antitrust laws to negotiations between groups of health care professionals and health plans and health care insurance issuers. (by CRS) Hide

To amend title XVIII of the Social Security Act to exempt blood glucose self-testing equipment and supplies furnished (regardless of method of delivery) by small retail community pharmacies from Medicare competitive acquisition programs and pricing. (by CRS) Hide

To ensure and foster continued safety and quality of care and a competitive marketplace by exempting independent pharmacies from the antitrust laws in their negotiations with health plans and health insurance insurers. (by CRS) Hide

To amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. (by CRS) Hide

To promote prosperity, creativity, entrepreneurship, and innovation by combating the theft of U.S. property, and for other purposes. (by CRS) Hide

To repeal the expansion of information reporting requirements for payments of $600 or more to corporations, and for other purposes. (by CRS) Hide

To amend chapter 6 of title 5, United States Code (commonly known as the Regulatory Flexibility Act), to ensure complete analysis of potential impacts on small entities of rules, and for other purposes. (by CRS) Hide

To amend the Internal Revenue Code of 1986 to repeal the expansion of information reporting requirements to payments made to corporations, payments for property and other gross proceeds, and rental property expense payments, and for other purposes. (by CRS) Hide

To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. (by CRS) Hide

A bill to repeal the expansion of information reporting requirements for payments of $600 or more to corporations and for other purposes. (by CRS) Hide

A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. (by CRS) Hide

A bill to delay the implementation of the health reform law in the United States until there is a final resolution in pending lawsuits. (by CRS) Hide

A bill to amend the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with improved capacity to prevent drug shortages. (by CRS) Hide

A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. (by CRS) Hide

A bill to amend the Public Health Service Act to improve women's health by prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. (by CRS) Hide

A bill to amend the Public Health Service Act to provide for the participation of pharmacists in National Health Services Corps programs, and for other purposes. (by CRS) Hide

A bill to repeal the expansion of information reporting requirements for payments of $600 or more to corporations, and for other purposes. (by CRS) Hide

To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes. (by CRS) Hide

An act to modernize the air traffic control system, improve the safety, reliability, and availability of transportation by air in the United States, provide for modernization of the air traffic control system, reauthorize the Federal Aviation Administration, and for other purposes. (by CRS) Hide

To amend the Small Business Act to provide loan guarantees for the acquisition of health information technology by eligible professionals in solo and small group practices, and for other purposes. (by CRS) Hide

To amend the Small Business Act and the Small Business Investment Act of 1958 to improve programs providing access to capital under such Acts, and for other purposes. (by CRS) Hide

To amend and reauthorize the controlled substance monitoring program under section 399O of the Public Health Service Act. (by CRS) Hide

HR 801 is a bill attempting to reverse the Public Access Policy of the National Institutes of Health that allows NIH to make freely available online peer-reviewed manuscripts within 12 months of their publication. (by CRS) Hide

A bill to amend the Controlled Substances Act to provide for take-back disposal of controlled substances in certain instances, and for other purposes. (by CRS) Hide

A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. (by CRS) Hide

To amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes. (by CRS) Hide

To amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes. (by CRS) Hide

To ensure and foster continued patient safety and quality of care by making the antitrust laws apply to negotiations between groups of independent pharmacies and health plans and health insurance issuers (including health plans under parts C and D of the Medicare Program) in the same manner as such laws apply to protected activities under the National Labor Relations Act. (by CRS) Hide

A bill to amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes. (by CRS) Hide